809 filings
Page 2 of 41
UPLOAD
45a gfu1gfg
21 Dec 23
Letter from SEC
12:00am
DEFA14A
cqihloa9aq
20 Dec 23
Additional proxy soliciting materials
4:59pm
DEFA14A
tnuhel6wbxxiof rsr86
20 Dec 23
Additional proxy soliciting materials
4:54pm
8-K
tg25jrn6cqr7gy jz5b3
1 Dec 23
Seelos Therapeutics Announces Closing of Public Offering
4:08pm
8-K
5briuup5je8bx4ouf5n
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
k3e tgob18vpu
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
n5xpa3opt1 5c1hx3h2
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
hjj ch2cl8f7p
28 Nov 23
Prospectus supplement
4:03pm
8-K
51n18le2
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
4pc2syue
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
ye2m q0f3gi8s9ow14
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
8-K
afagt9ncp2th 0lv3b8
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
5yc4j
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
8kfm01pzj9
2 Oct 23
Notice of effectiveness
12:15am
424B3
myvelk4z7u3y0d
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
uurs7ypw4mnq8ir igik
26 Sep 23
Correspondence with SEC
12:00am